Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis

被引:123
作者
Beach, Jocelyn M. [1 ]
Mihaljevic, Tomislav [2 ]
Rajeswaran, Jeevanantham [3 ]
Marwick, Thomas [4 ]
Edwards, Samuel T. [1 ]
Nowicki, Edward R. [2 ]
Thomas, James [4 ]
Svensson, Lars G. [2 ]
Griffin, Brian [4 ]
Gillinov, A. Marc [2 ]
Blackstone, Eugene H. [2 ,3 ]
机构
[1] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[2] Cleveland Clin Abu Dhabi, Inst Heart & Vasc, Dept Thorac & Cardiovasc Surg, Abu Dhabi, U Arab Emirates
[3] Cleveland Clin Abu Dhabi, Res Inst, Dept Quantitat Hlth Sci, Abu Dhabi, U Arab Emirates
[4] Cleveland Clin Abu Dhabi, Inst Heart & Vasc, Dept Cardiovasc Med, Abu Dhabi, U Arab Emirates
关键词
DIASTOLIC DYSFUNCTION; MYOCARDIAL FIBROSIS; MAGNETIC-RESONANCE; GENDER-DIFFERENCES; DISEASE; MASS; HYPERTENSION; MORTALITY; DECISION; MODERATE;
D O I
10.1016/j.jtcvs.2012.12.016
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives: We sought to understand the factors modulating left heart reverse remodeling after aortic valve replacement, the relationship between the preoperative symptoms and modulators of left heart remodeling, and their influence on long-term survival. Methods: From October 1991 to January 2008, 4264 patients underwent primary aortic valve replacement for aortic stenosis. Changes in the time course of left ventricular reverse remodeling were assessed using 5740 postoperative transthoracic echocardiograms from 3841 patients. Results: Left ventricular hypertrophy rapidly declined after surgery, from 137 +/- 42 g/m(2) preoperatively to 115 +/- 27 by 2 years and remained relatively constant but greater than the upper limit of normal. The most important risk factor for residual left ventricular hypertrophy was greater preoperative left ventricular hypertrophy (P <.0001). Other factors included a greater left atrial diameter (reflecting diastolic dysfunction), a lower ejection fraction, and male gender. An increased postoperative transprosthesis gradient was associated with greater residual left ventricular hypertrophy; however, its effect was minimal. Preoperative severe left ventricular hypertrophy and left atrial dilatation reduced long-term survival, independent of symptom status. Conclusions: Severe left ventricular hypertrophy with left atrial dilatation can develop from severe aortic stenosis, even without symptoms. These changes can persist, are associated with decreased long-term survival even after successful aortic valve replacement, and could be indications for early aortic valve replacement if supported by findings from an appropriate prospective study.
引用
收藏
页码:362 / +
页数:16
相关论文
共 33 条
[1]
Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing [J].
Amato, MCM ;
Moffa, PJ ;
Werner, KE ;
Ramires, JAF .
HEART, 2001, 86 (04) :381-386
[2]
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease [J].
Azevedo, Clerio F. ;
Nigri, Marcelo ;
Higuchi, Maria L. ;
Pomerantzeff, Pablo M. ;
Spina, Guilherme S. ;
Sampaio, Roney O. ;
Tarasoutchi, Flavio ;
Grinberg, Max ;
Rochitte, Carlos Eduardo .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (04) :278-287
[3]
Prosthesis size and long-term survival after aortic valve replacement [J].
Blackstone, EH ;
Cosgrove, DM ;
Jamieson, WRE ;
Birkmeyer, NJ ;
Lemmer, JH ;
Miller, DC ;
Butchart, EG ;
Rizzoli, G ;
Yacoub, M ;
Chai, AK .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (03) :783-796
[4]
THE DECOMPOSITION OF TIME-VARYING HAZARD INTO PHASES, EACH INCORPORATING A SEPARATE STREAM OF CONCOMITANT INFORMATION [J].
BLACKSTONE, EH ;
NAFTEL, DC ;
TURNER, ME .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1986, 81 (395) :615-624
[5]
Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI [10.1016/j.hrthm.2008.04.014, 10.1016/j.jacc.2008.05.007]
[6]
Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[7]
Does Left Atrial Size Predict Mortality in Asymptomatic Patients with Severe Aortic Stenosis? [J].
Casaclang-Verzosa, Grace ;
Malouf, Joseph F. ;
Scott, Christopher G. ;
Juracan, Eldyn Marcony ;
Nishimura, Rick A. ;
Pellikka, Patricia A. .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2010, 27 (02) :105-109
[8]
Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic cardiac obstruction-pilot study of enalapril in aortic stenosis (SCOPE-AS) [J].
Chockalingam, A ;
Venkatesan, S ;
Subramaniam, T ;
Jagannathan, V ;
Elangovan, S ;
Alagesan, R ;
Gnanavelu, G ;
Dorairajan, S ;
Krishna, BP ;
Chockalingam, V .
AMERICAN HEART JOURNAL, 2004, 147 (04) :740+L1-L8
[9]
Left atrial volume in patients with asymptomatic aortic valve stenosis (the simvastatin and ezetimibe in aortic stenosis study) [J].
Dalsgaard, Morten ;
Egstrup, Kenneth ;
Wachtell, Kristian ;
Gerdts, Eva ;
Cramariuc, Dana ;
Kjaergaard, Jesper ;
Hassager, Christian .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (07) :1030-1034
[10]
Exercise testing to stratify risk in aortic stenosis [J].
Das, P ;
Rimington, H ;
Chambers, J .
EUROPEAN HEART JOURNAL, 2005, 26 (13) :1309-1313